Search for: "State v. Bristol-Myers Squibb Company "
Results 101 - 120
of 159
Sorted by Relevance
|
Sort by Date
6 Jun 2013, 5:00 am
Bristol-Myers Squibb Co., No. 12 Civ. 2238 (JPO), slip op. [read post]
16 Feb 2021, 12:19 pm
Federal and state laws require similar elements to prove misappropriation of trade secrets. [read post]
18 Feb 2011, 11:47 am
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
3 Mar 2009, 5:55 am
" The term "slip ops" refers to court decisions that may or may not later be published officially in the New York State Reporter. [read post]
27 Jan 2017, 12:52 pm
The court also granted last Thursday in the much less colorful two-time relist Bristol-Myers Squibb Company v. [read post]
23 Jan 2018, 9:49 am
Bristol-Myers Squibb Co., et al. v. [read post]
19 Jul 2022, 2:59 pm
See, e.g., Sarafin v. [read post]
18 Jun 2012, 1:38 pm
In the back of the Court’s mind, of course, was January’s $99 million settlement by Novartis for overtime claims by its pharmaceutical sales representatives following the Second Circuit’s 2010 decision in In re Novartis Wage & Hour Litig., and similar pending cases against Johnson & Johnson, Merck Co. and Bristol-Myers Squibb. [read post]
15 Oct 2008, 3:02 pm
The Supreme Court wil shortly hear these arguments in the context of a drug case and FDA preamble that attempts to grant immunity, when Wyeth v. [read post]
24 Dec 2014, 5:00 am
Hood v. [read post]
20 Jan 2011, 12:50 pm
Bristol-Myers Squibb Co., 353 F.3d 848, 852 (10th Cir. 2003); In re Norplant Contraceptive Products Liability Litigation, 955 F. [read post]
4 Nov 2010, 6:14 am
”); Bristol-Myers Squibb Co. v. [read post]
14 Dec 2017, 10:48 pm
The remaining manufacturers, including Bristol-Myers Squibb, ultimately settled for $3.4 billion, and Dow Corning resolved its claims in bankruptcy court. [read post]
2 Nov 2009, 1:24 pm
At the Wall Street Journal, Dow Jones Newswire’s Kristina Peterson addresses the Court’s denial of cert. in a drug-patent dispute between generic drug manufacturer Apotex Corp. and patent-holders Sanofi-Aventis and Bristol-Myers Squibb, while the Associated Press has coverage of the Court’s decision not to hear an appeal to stop the release of documents relating to sexual abuse lawsuits against Roman Catholic priests in… [read post]
16 Feb 2010, 4:31 am
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
19 Feb 2021, 2:28 am
This second appeal followed with Bristol Myers Squibb Co., Pfizer Inc., and Eli Lilly and Company, among others, filing dueling amicus briefs. [read post]
20 May 2022, 10:26 am
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019). [9] See, e.g. [read post]
9 Nov 2022, 1:00 pm
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019). [9] See, e.g. [read post]
26 Feb 2015, 5:00 am
As stated in Henderson, pharmaceutical companies are held “to a high degree of responsibility under both the criminal and the civil law for any failure to exercise vigilance commensurate with the harm. [read post]
25 Jul 2023, 1:43 am
The facts Patent EP1427415 (“EP’415″) was filed in the name of Bristol-Myers Squibb Company (“BMS Company”) on September 17, 2002 in the form of international application PCT/US02/29491 (WO 03/026652) (“WO’652”), under the priority of provisional application US 60/324,165 of September 21, 2001. [read post]
